Claudia Zylberberg

Claudia is a trailblazer and visionary in the cell and gene therapy sector. She has played a pivotal role in enhancing the industry’s commercial readiness by leading global standardization initiatives, collaborating on efforts to develop a robust regulatory framework, integrating novel technologies into manufacturing workflows, and enabling clinical development and commercialization through the production of critical cGMP-compliant ancillary materials. With an immunology background, Claudia has contributed significantly to patents and publications that have advanced our understanding of and ability to industrialize these living therapies. Recognizing the need for a skilled labor force to sustain industry growth, she has spearheaded workforce development and education programs from K-12 to community college and beyond. Claudia’s contributions to the progress of the cell and gene therapy industry have been vital, and she will continue to execute her strategic vision at Akron and across the wider industry.